Nivanex DMX (Nivagen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Nivanex DMX drug offered from Nivagen Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nivagen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
SUBSTANCE NAME: | GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2014-11-24 |
END MARKETING DATE: | 0000-00-00 |
Nivanex DMX HUMAN OTC DRUG Details:
Item Description | Nivanex DMX from Nivagen Pharmaceuticals, Inc. |
LABELER NAME: | Nivagen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 380; 15; 10(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2014-11-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75834-040_908b202b-0135-41cd-97c1-dc6bd39f7204 |
PRODUCT NDC: | 75834-040 |
APPLICATION NUMBER: | part341 |
Other GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: